Carbopol emulgel loaded with ebastine for urticaria: development, characterization, in vitro and in vivo evaluation

References

• Ali Khan B, Ullah S, Khan MK, et al. (2020). Formulation and evaluation of Ocimum basilicum-based emulgel for wound healing using animal model. Saudi Pharm J 28:1842–50.
   PubMed Web of Science ®Google Scholar
• Bhasha SA. (2013). Recent trends in usage of polymers in the formulation of dermatological gels. Indian J Res Pharm Biotechnol 1:161–8.
   Google Scholar
• Burki IK, Khan MK, Khan BA, et al. (2020). Formulation development, characterization, and evaluation of a novel dexibuprofen-capsaicin skin emulgel with improved in vivo anti-inflammatory and analgesic effects. AAPS PharmSciTech 21:211–20.
   PubMed Web of Science ®Google Scholar
• Dannert C, Stokke BT, Dias RS. (2019). Nanoparticle–hydrogel composites: from molecular interactions to macroscopic behavior. Polymers 11:275.
   PubMed Web of Science ®Google Scholar
• Deng Y, Liu Z, Geng Y. (2016). Anti-allergic effect of Artemisia extract in rats. Exp Ther Med 12:1130–4.
   PubMed Web of Science ®Google Scholar
• Grattan CEH, Humphreys F, British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. (2007). Guidelines for evaluation and management of urticaria in adults and children. Br J Dermatol 157:1116–23.
   PubMed Web of Science ®Google Scholar
• Hampel F, Gillen M, Rohatagi SS, et al. (2002). A double-blind, placebo-controlled study of the efficacy and safety of ebastine 20 mg once daily given with and without food in the treatment of seasonal allergic rhinitis. J Clin Pharmacol 42:1097–104.
   PubMed Web of Science ®Google Scholar
• Harmalkar D, Godinho S, Bhide PJ, et al. (2019). New formulation technique for solubility and dissolution rate enhancement of poorly soluble drugs. Pharm Chem J 53:720–9.
   Web of Science ®Google Scholar
• Hosny KM, Aldawsari HM, Bahmdan RH, et al. (2019). Preparation, optimization, and evaluation of hyaluronic acid-based hydrogel loaded with miconazole self-nanoemulsion for the treatment of oral thrush. AAPS PharmSciTech 20:1–12.
   Web of Science ®Google Scholar
• Islam N, Irfan M, Zahoor AF, et al. (2021). Improved bioavailability of ebastine through development of transfersomal oral films. Pharmaceutics 13:1315.
   PubMed Web of Science ®Google Scholar
• Jadhav K, Shetye SL, Kadam VJ. (2010). Design and evaluation of microemulsion based drug delivery system. Int J Adv Pharm Sci 1:156–6.
   Google Scholar
• Kamisetti RR, Vankadari RMG. (2017). Solubility enhancement of ebastine by self-nanoemulsifying delivery strategy: formulation, optimization and characterization. Int J Pharm Sci Nanotechnol 10:3779–87.
   Google Scholar
• Khan BA, Khan A, Khan MK, Braga VA. (2020). Preparation and properties of high sheared poly(vinyl alcohol)/chitosan blended hydrogels films with Lawsonia inermis extract as wound dressing. J Drug Deliv Sci Technol 61:456–62.
   Web of Science ®Google Scholar
• Kumar V, et al. (2014). Emulgel based topical delivery system for loratadine. ADMET DMPK 2:254–71.
   Google Scholar
• Liu KH, Kim MG, Lee DJ, et al. (2006). Characterization of ebastine, hydroxyebastine, and carebastine metabolism by human liver microsomes and expressed cytochrome P450 enzymes: major roles for CYP2J2 and CYP3A. Drug Metab Dispos 34:1793–7.
   PubMed Web of Science ®Google Scholar
• Mahajan VR, Basarkar GD. (2019). Formulation, characterization, and in vitro–in vivo evaluation of self microemulsifying drug delivery system of ebastine by spray drying technology using solid carriers. Thai J Pharm Sci 43:146–60.
   Google Scholar
• Majumder J, Deb J, Husain A, et al. (2015). Cetirizine derived supramolecular topical gel in action: rational design, characterization and in vivo self-delivery application in treating skin allergy in mice. J Mater Chem B 3:6634–44.
   PubMed Web of Science ®Google Scholar
• Mehetre J, Vimal K, Mehta T, et al. (2019). Rationalized approach for formulation and optimization of ebastine microemulsion using design expert for solubility enhancement. J Drug Deliv Ther 9:386–97.
   Google Scholar
• Ormerod AD. (1994). Urticaria. Recognition, causes and treatment. Drugs 48:717–30.
   PubMed Web of Science ®Google Scholar
• Paul E, Greilich KD, Dominante G. (1987). Epidemiology of urticaria. Monogr Allergy 21:87–115.
   PubMedGoogle Scholar
• Prakash PR, Rao NGR, Soujanya C. (2010). Formulation, evaluation and anti-inflammatory activity of topical etoricoxib gel. Asian J Pharm Clin Res 3:126–9.
   Google Scholar
• Rohatagi S, Gillen M, Aubeneau M, et al. (2001). Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects. Int J Clin Pharmacol Ther 39:126–34.
   PubMed Web of Science ®Google Scholar
• Shahi S, Sonwane UM, Zadbuke N, Tadwee I. (2013). Design and development of diphenhydramine hydrochloride topical liposomal drug delivery system. Int J Pharm Pharm Sci 5:534–42.
   Google Scholar
• Tanwar Y, Jain AK. (2012). Formulation and evaluation of topical diclofenac sodium gel using different gelling agent. Asian J Pharm Res Health Care 4:1–6.
   Google Scholar
• Wiseman LR, Faulds D. (1996). Ebastine. A review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders. Drugs 51:260–77.
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Hashizume T, Matsuda M, et al. (1994). Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects. Arzneimittelforschung 44:59–64.
   PubMed Web of Science ®Google Scholar
• Yu Y-Q, Yang X, Wu X-F, Fan Y-B. (2021). Enhancing permeation of drug molecules across the skin via delivery in nanocarriers: novel strategies for effective transdermal applications. Front Bioeng Biotechnol 9:646554.
   PubMed Web of Science ®Google Scholar